Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Estradiol and Melatonin

supplement:

Melatonin

Research Papers that Mention the Interaction

A significant decrease of estradiol concentrations was observed after 6 months of the melatonin treatment in comparison to initial levels.
Neuro endocrinology letters  •  2002  |  View Paper
Both transdermal and oral estradiol treatment led to an increase as well as decrease of melatonin production in different patients.
International journal of clinical pharmacology and therapeutics  •  1995  |  View Paper
Progesterone, melatonin, and serotonin enhance hyperactivation through specific membrane receptors, and 17β-estradiol suppresses this enhancement by progesterone and melatonin via a membrane estrogen receptor.
The Journal of Physiological Sciences  •  2015  |  View Paper
We suggest that 17beta-estradiol differentially affects MT1 and MT2 melatonin receptor functions, attenuates melatonin responses through activation of MT1 receptors, and increases the MT2 receptors density.
Neuroendocrinology  •  2005  |  View Paper
melatonin , at a physiological concentration (1 nM) and in the presence of serum or estradiol: (a) inhibits, in a … cell cycle, and (c) reduces the metastasic capacity of these cells and counteracts the stimulatory effect of estradiol on cell invasiveness; this effect is … E-cadherin and beta(1)-integrin.
Endocrine-related cancer  •  2003  |  View Paper
Melatonin also counteracts the stimulatory effects of 17beta-estradiol on cell adhesion (P < 0.001).
The simultaneous addition of 17beta-estradiol and melatonin resulted in a significantly lower chemotactic response than that of 17beta-estradiol-treated cells (P < 0.001).
Cancer research  •  1998  |  View Paper
However, 17beta-estradiol exposure negated the ability of melatonin to inhibit proliferation.
Carcinogenesis  •  1998  |  View Paper
Melatonin (aMT) appears to be a potentially important oncostatic substance that can block the mitogenic effects of tumour-promoting hormones and growth factors such as oestradiol and epidermal growth factor, in vitro.
British Journal of Cancer  •  1995  |  View Paper
Melatonin (0.1 nM-1.0 μM) treatment inhibited estradiol (1.0 nM)-induced endometrial epithelial cell proliferation at 48 hours but not 24 hours of culture.
Human reproduction  •  2019  |  View Paper
Low baseline estradiol levels in our study population may have hindered the ability to detect any further estradiol-lowering effects of melatonin.
Cancer Causes & Control  •  2012  |  View Paper
Show More